drugset / Trial / NCT07084350

Combination of Lactulose and Polyethylene Glycol Electrolytes Powder (PEG-ELS) for Bowel Preparation in Type II Diabetes Mellitus Patients

NCT07084350

Not yet recruiting 254 enrolled General Hospital of Shenyang Military Region
RandomizedParallel-groupSingle-blindOther

Summary

Compared to the general population, diabetic patients have a significantly higher rate of inadequate bowel preparation. The European Society of Gastrointestinal Endoscopy (ESGE) guideline recommends polyethylene glycol (PEG) as the preferred bowel-cleansing agent, but there is currently no standardized bowel preparation protocol specifically for diabetic patients. Previous studies have shown that oral lactulose-based regimens or adding lactulose to the standard PEG protocol can improve bowel preparation quality, reduce adverse effects such as abdominal pain, bloating, nausea, and vomiting, and have no impact on blood glucose levels in diabetic patients after consuming 20g or 30g of lactulose. Herein, a multicenter randomized controlled trial(RCT) has been designed to explore the efficacy and safety of lactulose combined with polyethylene glycol electrolyte solution (PEG-ELS) for bowel preparation in patients with type II diabetes mellitus.

Timeline

Start
2025-08-25
Primary completion
2026-01-25
Completion
2026-07-25

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactulose Other / unclassified 30 ml Oral
Background PEG Unknown 2000 ml Oral